Aug 5, 2026 09:17AM
Jul 21, 2026 09:18AM
Jul 21, 2026 09:17AM
Jun 1, 2026 07:01AM
Jun 1, 2026 07:00AM
May 26, 2026 08:00AM
May 26, 2026 08:00AM Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
May 15, 2026 04:30PM
May 15, 2026 04:30PM
May 5, 2026 08:00PM
Apr 29, 2026 08:00AM
Apr 24, 2026 04:30PM
Apr 24, 2026 04:30PM
Apr 24, 2026 08:00AM Citius Pharmaceuticals raises $5 million in registered direct offering
Apr 24, 2026 08:00AM
Mar 31, 2026 09:13AM
Mar 31, 2026 09:11AM
Mar 24, 2026 08:00AM
Mar 10, 2026 08:47AM
Mar 10, 2026 08:47AM
Mar 4, 2026 09:15AM Citius Oncology reports positive phase 1 data for LYMPHIR cancer treatment
Mar 4, 2026 09:15AM
Feb 24, 2026 08:00AM
Feb 13, 2026 08:00AM
Feb 13, 2026 08:00AM
Feb 11, 2026 08:02AM
Feb 11, 2026 08:00AM
Dec 23, 2025 04:31PM Citius Pharmaceuticals launches cancer drug LYMPHIR following FDA approval
Dec 23, 2025 04:30PM
Dec 23, 2025 04:30PM
Dec 10, 2025 04:30PM
Dec 10, 2025 04:30PM
Dec 9, 2025 08:30AM
Dec 9, 2025 08:30AM
Dec 4, 2025 08:37AM Citius Oncology partners with Er-Kim for LYMPHIR distribution in Turkey, GCC
Dec 4, 2025 08:37AM
Dec 1, 2025 12:08PM
Dec 1, 2025 12:00PM
Nov 25, 2025 08:00AM
Nov 21, 2025 08:37AM
Oct 21, 2025 04:30PM
Oct 21, 2025 04:30PM Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules
Oct 21, 2025 08:01AM
Oct 21, 2025 08:00AM
Oct 20, 2025 08:38AM
Oct 20, 2025 08:37AM
Oct 17, 2025 05:00PM
Oct 16, 2025 08:47AM
Oct 16, 2025 08:47AM Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
Oct 7, 2025 08:47AM

327,799 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All